MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0004678
Hindustan Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹227.37 Cr
▲ 17% YoY
Net profit · FY 2025
₹41.26 Cr
Net margin 18.1%
EBITDA · FY 2025
₹61.5 Cr
EBITDA margin 27%
Authorised capital
₹60 Cr
Registered with MCA
Paid-up capital
₹49.86 Cr
Issued & subscribed
Open charges
₹65 Cr
Satisfied ₹70 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
104
Provident fund records
About Hindustan Laboratories Limited
Data last updated:
Hindustan Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 June 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2017PLC296158. Its GSTIN is 27AAECH2208Q1ZC (Maharashtra). The company holds 5 GST registrations, all of them active.
The company has an authorised share capital of ₹60 Cr and a paid-up capital of ₹49.86 Cr. It is led by directors including Rajesh Vasantray Doshi (Managing Director) and Bhavik Jayantilal Sanghavi.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 302 A Wing Victory Park Chandavarkar Road Borivali West, Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹227.37 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹41.26 Cr (net margin 18.1%) and EBITDA of ₹61.5 Cr (EBITDA margin 27%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years.
The company has about 104 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Hindustan Laboratories Limited. As per MCA filings, the company has open charges of ₹65 Cr and satisfied charges of ₹70 Cr on record. Court records list 20 cases involving the company, including 8 filed by the company and 12 filed against it; 11 cases are pending. The company has 1 deal on record (1 funding round), with disclosed funding of ₹49.85 Cr; the latest was in September 2020. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Axa Parenterals Limited with revenue of ₹231.46 Cr. The company has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 86 overdue payments to 43 micro and small suppliers.
Hindustan Laboratories Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0004678). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hindustanlaboratories.com.
Company details
CIN U24100MH2017PLC296158
Registration Number 296158
Incorporation Date 14 June 2017
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-18-0004678
Key People
Rajesh Vasantray Doshi Managing Director Bhavik Jayantilal Sanghavi Director Ishika Bansal Director Recognitions & Rankings of Hindustan Laboratories
Contact details
Hindustan Laboratories Limited's registered office is in Mumbai, Maharashtra. Its website is hindustanlaboratories.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address302 A Wing Victory Park Chandavarkar Road Borivali West, Mumbai, Maharashtra, India – 400092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Hindustan Laboratories Limited, buy the company report.
Comprehensive company report
Hindustan Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Hindustan Laboratories operates one associated brand: Hindustan Laboratories Limited. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and supply of medicines in India. | hindustanlaboratories.com |
Business activity
The main business activity of Hindustan Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hindustan Laboratories Limited, buy the company report.
Financials of Hindustan Laboratories Limited
FY 2024 filings availableHindustan Laboratories Limited reported revenue of ₹227.37 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹227.37 Cr ▲ 17%
Net profit · FY 2025
₹41.26 Cr margin 18.1%
EBITDA · FY 2025
₹61.5 Cr margin 27%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 16%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▲ 27%
Revenue has grown at a compounded annual rate (CAGR) of 16% over three years, including 17% growth in the latest year. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61.5 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.26 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 27% | ||||
| Net Profit Margin | 18.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hindustan Laboratories Limited, buy the company report.
Board of directors of Hindustan Laboratories Limited
Hindustan Laboratories has 8 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Vasantray Doshi | Managing Director | 14 Jun 2017 | 9 Years 4 Months | Current |
| Bhavik Jayantilal Sanghavi Also directs: Puj & Associates LLP | Director | 13 Dec 2023 | 2 Years 10 Months | Current |
| Ishika Bansal Also directs: Utssav CZ Gold Jewels Limited | Director | 13 Dec 2023 | 2 Years 10 Months | Current |
| Brijendrakumar Ramprasad Shukla | Director | 11 Mar 2024 | 2 Years 7 Months | Current |
| Krishiv Rajesh Doshi | Director | 11 Aug 2025 | 1 Years 2 Months | Current |
| Kunjal Chandrakant Dedhia Also directs: Hindustan Realty Limited | Director | 14 Jun 2017 | 9 Years 4 Months | Current |
Showing 6 of 8 current directors. View all directors
Peer comparison
Hindustan Laboratories Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axa Parenterals Limited | ₹231.46 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Ahlcon Parenterals (India) Limited | ₹229.53 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Medopharm Private Limited | ₹229.32 Cr (FY 2025) | -9.0% | Chennai, Tamil Nadu, India | |||
| Hindustan Laboratories Limitedthis company | ₹227.37 Cr (FY 2025) | ₹41.26 Cr | 18.1% | 17.0% | 104 | Mumbai, Maharashtra, India |
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Venus Biosciences Private Limited | ₹222.32 Cr (FY 2016) | 48.0% | Solan, Himachal Pradesh, India | |||
| Nestor Pharmaceuticals Limited | ₹222.19 Cr (FY 2025) | 8.0% | New Delhi, Delhi, India | |||
| Concept Pharmaceuticals Limited | ₹222.11 Cr (FY 2024) | -29.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Hindustan Laboratories Limited, buy the company report.
Auditor
Hindustan Laboratories Limited is audited by TMG & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| TMG & Associates | FY 2023 | 111635W |
Shareholding
The shareholding of Hindustan Laboratories Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hindustan Laboratories Limited, buy the company report.
Charges & borrowings
Open charges
₹65 Cr
Satisfied charges
₹70 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Aug 2023 | 100776708 | Others | ₹15 Cr | Open | |
| 09 Aug 2023 | 100770850 | Others | ₹50 Cr | Open | |
| 16 Sep 2021 | 100494557 | Hdfc Bank Limited | ₹35 Cr | Satisfied | |
| 28 Oct 2020 | 100382755 | Others | ₹35 Cr | Satisfied |
To see the full charge records of Hindustan Laboratories Limited, buy the company report.
Total charge records: 4 View all charges
Deals & funding
Hindustan Laboratories Limited has 1 deal on record (1 funding round), with disclosed funding of ₹49.85 Cr; the latest was in September 2020.
Total deals
1
Funding round
1
Disclosed funding
₹49.85 Cr
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2020 | Funding round | ₹49.85 Cr | Investors: an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Hindustan Laboratories Limited has 20 court cases on record: 8 filed by Hindustan Laboratories, 12 filed against it. 11 cases are pending and 9 are disposed.
Total cases
20
Filed by the company
8
Filed against the company
12
Pending
11
Disposed
9
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 13 | 12 | 5 |
| High courts | 7 | 0 | 6 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against Karnataka State Medical Supplies Corporation Limited, and 1 other | Pending |
| High Court of Gujarat | Special civil application | Filed by the company against Gujarat Medical Services Corporation Limited | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons cases SS) | Filed against the company by State of Maharashtra Through of Drugs Inspector Shri Ajay M Mahule | Pending |
| District court, Raigad, Maharashtra | Civil suit | Filed against the company | Pending |
| Bombay High Court | Writ petition | Filed by the company against Maharashtra Medical Goods Procurement Authority | Pending |
To see the full case history of Hindustan Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Hindustan Laboratories Limited was last rated by Care on 05 Apr 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 05 Apr 2022 |
To see the full credit ratings and regulatory alerts of Hindustan Laboratories Limited, buy the company report.
MSME payment delays
Hindustan Laboratories Limited has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 86 overdue payments to 43 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 43)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Appli Tech Information Systems | |||
| an individual supplier | |||
| Classicart Prints Private Limited | |||
| Essenza |
To see the full MSME payment records of Hindustan Laboratories Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Hindustan Laboratories Limited has a workforce of 104 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
104
Active EPFO establishments
1
Employee growth
8.33%
GST
Hindustan Laboratories has 5 GST registrations: 5 active. The first 4 active GSTINs are listed below.
Total GSTINs
5
Active
5
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECH2208Q1ZC | Maharashtra | Active | 03 Mar 2020 |
| 29AAECH2208Q1Z8 | Karnataka | Active | 25 May 2020 |
| 09AAECH2208Q1ZA | Uttar Pradesh | Active | 11 Jun 2020 |
| 21AAECH2208Q1ZO | Odisha | Active | 03 Jul 2020 |
To see the full GST registrations and return filing status of Hindustan Laboratories Limited, buy the company report.
Recent activity
Hindustan Laboratories Limited has 15 board changes on record since 2017: 8 appointments and 7 cessations. The latest: Dambarudhar Sahu ceased to be Additional Director on 29 Sep 2025.
Ceased
Dambarudhar Sahu ceased to be Additional Director.
Ceased
Krishiv Rajesh Doshi ceased to be Additional Director.
Appointed
Dambarudhar Sahu was appointed as Director.
Appointed
Krishiv Rajesh Doshi was appointed as Director.
Ceased
Vijay Manharlal Gadhia ceased to be Director.
Ceased
Dayanad Shivshankar Mathapati ceased to be Additional Director.
Appointed
Dayanad Shivshankar Mathapati was appointed as Additional Director.
Ceased
Brijendrakumar Ramprasad Shukla ceased to be Director.
Charges
A charge with Others of Rs. 50.00 Cr registered on 09 Aug 2023 with Charge ID 100770850 was modified on 27 Feb 2025.
AGM
Hindustan Laboratories Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Hindustan Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Brijendrakumar Ramprasad Shukla was appointed as Director.
13 earlier events are in the company report.
News
Frequently asked questions
Hindustan Laboratories is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 June 2017 (9+ years old) and is registered under CIN U24100MH2017PLC296158.
Hindustan Laboratories has 8 current directors:
- Rajesh Vasantray Doshi - Managing Director
- Bhavik Jayantilal Sanghavi - Director
- Ishika Bansal - Director
- Brijendrakumar Ramprasad Shukla - Director
- Krishiv Rajesh Doshi - Director
- Kunjal Chandrakant Dedhia - Director
- Dayanad Shivshankar Mathapati - Additional Director
- Dambarudhar Sahu - Director
The latest financial statements of Hindustan Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Hindustan Laboratories is 27AAECH2208Q1ZC, registered in Maharashtra. The company has 5 GST registrations in all, of which 5 are active. Other active GSTINs include 29AAECH2208Q1Z8 (Karnataka), 09AAECH2208Q1ZA (Uttar Pradesh), 21AAECH2208Q1ZO (Odisha).
The CIN (Corporate Identification Number) of Hindustan Laboratories is U24100MH2017PLC296158. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hindustan Laboratories has 20 court cases on record: 8 filed by the company and 12 filed against it. 11 are pending. Most are in the district courts.
Hindustan Laboratories was incorporated on 14 June 2017, making it 9+ years old. It is registered with the Registrar of Companies, Mumbai.
Hindustan Laboratories has 1 deal on record (1 funding round), with disclosed funding of ₹49.85 Cr; the latest was in September 2020.
The peers of Hindustan Laboratories by revenue are Axa Parenterals Limited, Dosch Pharmaceuticals Private Limited, Ahlcon Parenterals (India) Limited, Medopharm Private Limited, Salvi Chemical Industries Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dambarudhar Sahu ceased to be Additional Director on 29 Sep 2025. Krishiv Rajesh Doshi ceased to be Additional Director on 29 Sep 2025. Dambarudhar Sahu was appointed as Director on 11 Aug 2025. Hindustan Laboratories has 15 board changes on record in total.
Yes, Hindustan Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0004678).
Hindustan Laboratories has 2 MSME Form 1 returns on record for the period ending Sep 2021, listing 86 overdue payments to 43 micro and small suppliers. The latest return was filed on 30 Oct 2021.